Author:
MURPHY G.,PILCHER C. D.,KEATING S. M.,KASSANJEE R.,FACENTE S. N.,WELTE A.,GREBE E.,MARSON K.,BUSCH M. P.,DAILEY P.,PARKIN N.,OSBORN J.,ONGARELLO S.,MARSH K.,GARCIA-CALLEJA J. M.
Abstract
SUMMARYIn 2011 the Incidence Assay Critical Path Working Group reviewed the current state of HIV incidence assays and helped to determine a critical path to the introduction of an HIV incidence assay. At that time the Consortium for Evaluation and Performance of HIV Incidence Assays (CEPHIA) was formed to spur progress and raise standards among assay developers, scientists and laboratories involved in HIV incidence measurement and to structure and conduct a direct independent comparative evaluation of the performance of 10 existing HIV incidence assays, to be considered singly and in combinations as recent infection test algorithms. In this paper we report on a new framework for HIV incidence assay evaluation that has emerged from this effort over the past 5 years, which includes a preliminary target product profile for an incidence assay, a consensus around key performance metrics along with analytical tools and deployment of a standardized approach for incidence assay evaluation. The specimen panels for this evaluation have been collected in large volumes, characterized using a novel approach for infection dating rules and assembled into panels designed to assess the impact of important sources of measurement error with incidence assays such as viral subtype, elite host control of viraemia and antiretroviral treatment. We present the specific rationale for several of these innovations, and discuss important resources for assay developers and researchers that have recently become available. Finally, we summarize the key remaining steps on the path to development and implementation of reliable assays for monitoring HIV incidence at a population level.
Publisher
Cambridge University Press (CUP)
Subject
Infectious Diseases,Epidemiology
Reference39 articles.
1. Analysis of HIV Using a High Resolution Melting (HRM) Diversity Assay: Automation of HRM Data Analysis Enhances the Utility of the Assay for Analysis of HIV Incidence
2. Kassanjee R , The performance of candidate assays to detect recent HIV infection for cross-sectional estimation: An independent comparative evaluation. Conference on Retroviruses and Opportunistic Infections, Atlanta 2013, p. 1056.
3. New Testing Strategy to Detect Early HIV-1 Infection for Use in Incidence Estimates and for Clinical and Prevention Purposes
4. Bill & Melinda Gates Foundation Letters of Inquiry (LOI). New biomarkers for HIV incidence measurement (https://docs.gatesfoundation.org/documents/hiv-incidence-rules-and-guidelines.pdf). Accessed 29 March 2014.
5. A simple and inexpensive particle agglutination test to distinguish recent from established HIV-1 infection
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献